Statutory Price Disclosure For Colorado Prescribers

Notice to Colorado Prescribers

This information is being provided pursuant to Colorado HB 19-1131. The information is accurate as of April 13, 2021. The prices listed are WAC prices, which represent Pfizer’s published list prices for the products sold to wholesalers, before any discount, rebate, or other price reduction. The WAC prices listed may differ significantly from actual prices paid by customers and consumers. In addition, a product’s WAC is typically not associated with per-dose pricing, and does not necessarily reflect price per dosage, price per course of treatment or the cost effectiveness of all the products listed. This list does not imply that the products are interchangeable or have the same efficacy or safety. Please refer to each product's FDA-approved label and indication for further information. Pricing information listed does not imply safety or efficacy of the product, and no comparisons should be made.

"Generic Products"

The "Generic Products" identified on the forms are generic products listed in the same therapeutic class. Colorado HB 19-1131 has defined “Therapeutic Class” as:

“Therapeutic Class” means a group of similar drugs that have the same or similar mechanisms of action and are used to treat a specific condition.

The listing of "generic products" is not intended to imply that such generic products are interchangeable with the marketed product.

More Information

For more information on the price disclosure requirements, please contact the Colorado State Board of Pharmacy’s office:

State Board of Pharmacy
1560 Broadway, Suite 1350
Denver, CO 80202
Ph. (303) 894-7800 | Fax: (303) 894-7692 | Email: [email protected]

Marketed Products